Augurex
PRIVATE
STATUS
1-10
EMPLOYEES
Early Stage VC
LATEST DEAL TYPE
3
INVESTORS
Description
Owner and operator of a biotechnology company intended to focus on developing bio-marker blood tests. The company's biotechnology services includes developing bio-markers to diagnose patients by predicting which treatment will personally offer maximum therapeutic benefit while minimizing side effects, enabling patients to the benefit of earlier detection of diseases.
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Therapeutic Devices
Primary Office
- 887 Great Northern Way
- Suite 125-1
- Vancouver, British Columbia V5T 4T5
- Canada
+1 (604) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Augurex’s full profile, request a free trial.
Augurex Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Early Stage VC | 25-Jan-2017 | 00000 | Completed | Startup | ||
| 4. Angel (individual) | 01-Feb-2011 | 000.00 | 00000 | Completed | Startup | |
| 3. Angel (individual) | 01-May-2009 | 000.00 | 000.00 | Completed | Startup | |
| 2. Angel (individual) | 01-Nov-2007 | $52.8K | $52.8K | Completed | Startup | |
| 1. Grant | 01-Jan-2007 | $52.8K | Completed | Startup |
Augurex Competitors (16)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Adverum Biotechnologies | Formerly VC-backed | Menlo Park, CA | 00 | 00000 | 000000 - 000 | 00000 |
| 000000 00000000000 | Formerly VC-backed | Bedford, MA | 000 | 00000 | 00000000000 | 00000 |
| 00000000 | Venture Capital-Backed | Carrollton, TX | 00 | 000.00 | 00 000000 | 000.00 |
| 000000000 | Formerly PE-Backed | Geneva, Switzerland | 000.00 | 0&0 | ||
| 000000000 00000000 | Formerly VC-backed | Alpharetta, GA | 00 | 00000 | 000000 - 000 | 00000 |
Augurex Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Genome British Columbia | Not-For-Profit Venture Capital | Minority | 000 0000 | 000000 0 | ||
| WUTIF Capital | Angel Group | Minority | 000 0000 | 000000 0 | ||
| New Ventures BC | Accelerator/Incubator | 000 0000 | 000000 0 |
Augurex Executive Team (2)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| Norma Biln | Co-Founder & Chief Executive Officer | ||
| Anthony Marotta Ph.D | Co-Founder & CSO |